Xu Teng

685 total citations
29 papers, 456 citations indexed

About

Xu Teng is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Xu Teng has authored 29 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Surgery and 8 papers in Cancer Research. Recurrent topics in Xu Teng's work include Helicobacter pylori-related gastroenterology studies (6 papers), Inflammatory Bowel Disease (5 papers) and RNA modifications and cancer (5 papers). Xu Teng is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (6 papers), Inflammatory Bowel Disease (5 papers) and RNA modifications and cancer (5 papers). Xu Teng collaborates with scholars based in China. Xu Teng's co-authors include Mei Sun, Lingfen Xu, Ping Zhou, Ruizhi Fan, Yixin Xu, Song Hu, Jing Guo, Meng Cao, Jing Guo and Jie Wu and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and Molecular Cancer.

In The Last Decade

Xu Teng

27 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Teng China 12 234 143 88 56 46 29 456
Zewei Zhuo China 12 235 1.0× 82 0.6× 58 0.7× 44 0.8× 68 1.5× 36 462
Jianbo Xu China 13 183 0.8× 124 0.9× 77 0.9× 85 1.5× 66 1.4× 35 470
Bohao Liu China 12 182 0.8× 113 0.8× 89 1.0× 54 1.0× 55 1.2× 25 492
Xinyu Shao China 11 333 1.4× 122 0.9× 83 0.9× 61 1.1× 70 1.5× 29 585
Seung Young Seo South Korea 13 237 1.0× 180 1.3× 85 1.0× 39 0.7× 57 1.2× 46 487
Yiyuan Pan China 14 202 0.9× 103 0.7× 179 2.0× 66 1.2× 77 1.7× 20 456
Jan Dimberg Sweden 15 167 0.7× 117 0.8× 91 1.0× 76 1.4× 45 1.0× 32 512
Dongmei Zhou China 15 279 1.2× 165 1.2× 44 0.5× 79 1.4× 43 0.9× 37 526

Countries citing papers authored by Xu Teng

Since Specialization
Citations

This map shows the geographic impact of Xu Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Teng more than expected).

Fields of papers citing papers by Xu Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Teng. The network helps show where Xu Teng may publish in the future.

Co-authorship network of co-authors of Xu Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Teng. A scholar is included among the top collaborators of Xu Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Teng. Xu Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Teng, Xu, et al.. (2025). The efficacy and underlying mechanisms of berberine in the treatment of recurrent Clostridioides difficile infection. International Journal of Antimicrobial Agents. 65(5). 107468–107468. 4 indexed citations
3.
Teng, Xu, Yuemei Yang, Zhihong Chen, et al.. (2023). TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling. Journal of Experimental & Clinical Cancer Research. 42(1). 190–190. 24 indexed citations
4.
Teng, Xu, et al.. (2022). Development of a risk prediction model for bloodstream infection in patients with fever of unknown origin. Journal of Translational Medicine. 20(1). 575–575. 3 indexed citations
5.
Chen, Ying, et al.. (2022). Clinical and genetic analysis in Chinese children with Alagille syndrome. BMC Pediatrics. 22(1). 688–688. 6 indexed citations
6.
Zheng, Yang, Chao Wang, Yuemei Yang, et al.. (2021). Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway. Cell Communication and Signaling. 19(1). 121–121. 9 indexed citations
7.
Teng, Xu, et al.. (2020). Effect of Exclusive Enteral Nutrition on Th17 Cells in Juvenile Rats with Inflammatory Bowel Disease. Inflammation. 44(1). 261–269. 2 indexed citations
8.
Teng, Xu, Lu Liu, Lijuan Yang, et al.. (2020). Evaluation of inflammatory bowel disease activity in children using serum trefoil factor peptide. Pediatric Research. 88(5). 792–795. 7 indexed citations
9.
Teng, Xu, et al.. (2020). Utility of a Simple Scoring System in Differentiating Bacterial Infections in Cases of Fever of Unknown Origin. Clinical Infectious Diseases. 71(Supplement_4). S409–S415. 10 indexed citations
10.
Hu, Song, Yixin Xu, Xu Teng, et al.. (2018). LncRNA THOR increases the stemness of gastric cancer cells via enhancing SOX9 mRNA stability. Biomedicine & Pharmacotherapy. 108. 338–346. 56 indexed citations
11.
Guo, Jing, Mei Sun, Xu Teng, & Lingfen Xu. (2017). MicroRNA-7-5p regulates the expression of TFF3 in inflammatory bowel disease. Molecular Medicine Reports. 16(2). 1200–1206. 17 indexed citations
12.
Teng, Xu, et al.. (2017). Clinical significance of fecal calprotectin for the early diagnosis of abdominal type of Henoch–Schonlein purpura in children. Clinical Rheumatology. 37(6). 1667–1673. 11 indexed citations
13.
Teng, Xu, et al.. (2016). The effects of IL-1 beta on intestinal epithelial barrier permeability. International journal of pediatrics. 43(5). 409–412. 1 indexed citations
14.
Liu, Tianjing, Yongyan Shi, Jie Du, et al.. (2016). Vitamin D treatment attenuates 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis but not oxazolone-induced colitis. Scientific Reports. 6(1). 32889–32889. 38 indexed citations
15.
Teng, Xu, et al.. (2014). Evaluation of serum procalcitonin and C-reactive protein levels as biomarkers of Henoch-Schönlein purpura in pediatric patients. Clinical Rheumatology. 35(3). 667–671. 15 indexed citations
16.
Zhou, Ping, et al.. (2013). Therapeutic potential of EGCG on acute renal damage in a rat model of obstructive nephropathy. Molecular Medicine Reports. 7(4). 1096–1102. 39 indexed citations
17.
Xu, Lingfen, et al.. (2011). Disruption of the F-actin cytoskeleton and monolayer barrier integrity induced by PAF and the protective effect of ITF on intestinal epithelium. Archives of Pharmacal Research. 34(2). 245–251. 20 indexed citations
18.
Xu, Lingfen, Xu Teng, Jing Guo, & Mei Sun. (2011). Protective Effect of Intestinal Trefoil Factor on Injury of Intestinal Epithelial Tight Junction Induced by Platelet Activating Factor. Inflammation. 35(1). 308–315. 42 indexed citations
19.
Teng, Xu, Lingfen Xu, Ping Zhou, Hong‐Wei Sun, & Mei Sun. (2009). Effects of Trefoil Peptide 3 on Expression of TNF-α, TLR4, and NF-κB in Trinitrobenzene Sulphonic Acid Induced Colitis Mice. Inflammation. 32(2). 120–129. 40 indexed citations
20.
Teng, Xu. (2006). Effects of vitamin C polyphosphate on antioxidase gene transcription activity in mouse liver. Dongwu xuebao. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026